BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 23870808)

  • 1. CYP450 pharmacogenetic treatment strategies for antipsychotics: a review of the evidence.
    Ravyn D; Ravyn V; Lowney R; Nasrallah HA
    Schizophr Res; 2013 Sep; 149(1-3):1-14. PubMed ID: 23870808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.
    Arranz MJ; de Leon J
    Mol Psychiatry; 2007 Aug; 12(8):707-47. PubMed ID: 17549063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome p450 phenotyping/genotyping in patients receiving antipsychotics: useful aid to prescribing?
    Dahl ML
    Clin Pharmacokinet; 2002; 41(7):453-70. PubMed ID: 12083975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenetics of antipsychoatics.
    Ozaki N
    Nagoya J Med Sci; 2004 May; 67(1-2):1-7. PubMed ID: 15279062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochrome P450 polymorphisms and response to antipsychotic therapy.
    Scordo MG; Spina E
    Pharmacogenomics; 2002 Mar; 3(2):201-18. PubMed ID: 11972442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetics and antipsychotics in the light of personalized pharmacotherapy.
    Mihaljević-Peles A; Sagud M; Bozina N; Zivković M; Jovanović N
    Psychiatr Danub; 2010 Jun; 22(2):335-7. PubMed ID: 20562776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical effectiveness and cost-effectiveness of testing for cytochrome P450 polymorphisms in patients with schizophrenia treated with antipsychotics: a systematic review and economic evaluation.
    Fleeman N; McLeod C; Bagust A; Beale S; Boland A; Dundar Y; Jorgensen A; Payne K; Pirmohamed M; Pushpakom S; Walley T; de Warren-Penny P; Dickson R
    Health Technol Assess; 2010 Jan; 14(3):1-157, iii. PubMed ID: 20031087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High levels of several antipsychotics and antidepressants due to a pharmacogenetic cause: a case report.
    Mian P; Somers M; Berg MT; Cahn W; Wilting I; Schaik RV
    Pharmacogenomics; 2019 Jun; 20(8):567-570. PubMed ID: 31190622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacogenetics as a tool in the therapy of schizophrenia.
    Wilffert B; Zaal R; Brouwers JR
    Pharm World Sci; 2005 Feb; 27(1):20-30. PubMed ID: 15861931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P450 testing for prescribing antipsychotics in adults with schizophrenia: systematic review and meta-analyses.
    Fleeman N; Dundar Y; Dickson R; Jorgensen A; Pushpakom S; McLeod C; Pirmohamed M; Walley T
    Pharmacogenomics J; 2011 Feb; 11(1):1-14. PubMed ID: 20877299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics of antipsychotics: useful for the clinician?
    Bondy B; Spellmann I
    Curr Opin Psychiatry; 2007 Mar; 20(2):126-30. PubMed ID: 17278909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetics of psychotropic drug response.
    Malhotra AK; Murphy GM; Kennedy JL
    Am J Psychiatry; 2004 May; 161(5):780-96. PubMed ID: 15121641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics and antipsychotic treatment response.
    Naumovska Z; Nestorovska AK; Filipce A; Sterjev Z; Brezovska K; Dimovski A; Suturkova LJ
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2015; 36(1):53-67. PubMed ID: 26076775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenomics of antipsychotics efficacy for schizophrenia.
    Cacabelos R; Hashimoto R; Takeda M
    Psychiatry Clin Neurosci; 2011 Feb; 65(1):3-19. PubMed ID: 21265934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of CYP pharmacogenetics and drug-drug interactions in the efficacy and safety of atypical and other antipsychotic agents.
    Murray M
    J Pharm Pharmacol; 2006 Jul; 58(7):871-85. PubMed ID: 16805946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The relationship of cytochrome P450 isoforms with the efficacy and safety of antipsychotic and antidepressant therapy].
    Bairamova SP; Pavlova OV; Shport SV; Gurina OI; Pavlov KA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(11):40-46. PubMed ID: 37994887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacogenetics and tailored drug treatment in schizophrenia].
    Andreassen OA; Steen VM
    Tidsskr Nor Laegeforen; 2006 Sep; 126(18):2400-2. PubMed ID: 16998555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical pharmacogenetics in the treatment of schizophrenia].
    Saito M; Yasui-Furukori N; Kaneko S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2005 Jun; 25(3):129-35. PubMed ID: 16045195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics of antipsychotic treatment in schizophrenia.
    Pouget JG; Müller DJ
    Methods Mol Biol; 2014; 1175():557-87. PubMed ID: 25150876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenomic potential of psychiatric medications and CYP2D6.
    Foley KF; Quigley DI
    MLO Med Lab Obs; 2010 Jan; 42(1):32-4. PubMed ID: 20180465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.